Acetazolamide Injection Solution and Aminolevulinic Acid (Systemic)
Determining the interaction of Acetazolamide Injection Solution and Aminolevulinic Acid (Systemic) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid. MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid. References "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Professional:GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid.
MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid.
- "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Generic Name: acetazolamide
Brand name: Diamox, Diamox Sequels
Synonyms: Acetazolamide, AcetaZOLAMIDE
Generic Name: aminolevulinic acid
Brand name: Gleolan
Synonyms: Aminolevulinic acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acetazolamide Injection Solution-Aminolevulinic Acid Gel
- Acetazolamide Injection Solution-Aminolevulinic Acid Hydrochloride
- Acetazolamide Injection Solution-Aminolevulinic Acid Solution
- Acetazolamide Injection Solution-Aminolevulinic acid topical
- Acetazolamide Injection Solution-Aminomine
- Acetazolamide Injection Solution-Aminophylline
- Aminolevulinic Acid (Systemic)-Acetazolamide Sodium
- Aminolevulinic Acid (Systemic)-Acetazolamide Sustained-Release Capsules
- Aminolevulinic Acid (Systemic)-Acetazolamide Tablets
- Aminolevulinic Acid (Systemic)-Acetohydroxamic acid
- Aminolevulinic Acid (Systemic)-Acetoxyl 10 Topical
- Aminolevulinic Acid (Systemic)-Acetoxyl 2.5 Topical